AzTrials
AzTrials

General AnesthesiaNCT05063461

Evaluation of the Analgesia Nociception Index With Varying Remifentanil Concentrations Under Sevoflurane

A study testing Tetanic stimulation and Skin incision in people with General Anesthesia, run by Beijing Chao Yang Hospital at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Analgesia Nociception Index(ANI)which is derived from heart rate variability can be used to detect noxious stimulation during propofol while changing remifentanil concentrations. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
General Anesthesia
What is being tested?
Tetanic stimulation and Skin incision
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteChina
Study dates
25 Sep 2021to 1 Mar 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age between 18- 65 years
  • ASA physical status I or II
  • Elective surgery in general anesthesia planned
  • Written informed consent

Who cannot join

  • Use of CNS-active medication or abuse of alcohol
  • Presents of any neuromuscular or neurologic disease
  • History of cardiac arrhythmia
  • Pregnancy or using a pacemaker

Trial locations and contacts

1 site in 1 country.

China1 site
  • Beijing Chao Yang Hospital

    Beijing, Beijing Municipality, 100020

Other trials in China

About this study

Analgesia Nociception Index(ANI)which is derived from heart rate variability can be used to detect noxious stimulation during propofol while changing remifentanil concentrations. The aim of this study is to verify the effectiveness of ANI predictability for actual surgical noxious stimuli while satisfying the individual analgesic status by pre-tetanus-induced ANI determination during sevoflurane while changing remifentanil concentrations.

Read the detailed description

General anesthesia with sevoflurane and remifentanil is widely used in minor surgeries. Monitoring noxious stimulation during general anesthesia is still worth further studies and reaching clinical consensus. Analgesia Nociception Index can be used to detect noxious stimulation during propofol while changing remifentanil concentrations. Previous studies suggest that an ANI≥50 can be useful in detecting sufficient analgesia for patients who cannot self-report pain. The aim of this study is to verify the effectiveness of ANI predictability for actual surgical noxious stimuli while satisfying the individual analgesic status by pre-tetanus-induced ANI determination during sevoflurane while changing remifentanil concentrations.

Being tested
Tetanic stimulation, Skin incision

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tetanic stimulationDevice

    For each participant, record the first concentration that ANI≥50 after the tetanic stimuli, as the sufficient concentration.

  • Skin incisionProcedure or surgery

    Infuse the sufficient concentration for at least 5min of the steady-state period, then surgical stimulus is applied. The surgical stimulus is defined as the first skin incision to establish pneumoperitoneum.

Study groups in NCT05063461
Study groupRoleWhat they receive
Sevoflurane with different site effect concentrations of remifentanilExperimentalThe tetanic stimulus is conducted between laryngeal mask intubation and surgical stimulation, while no other noxious stimuli are presented. The effect site concentration of remifentanil is increased step-by-step via a Target Controlled infusion device to a concentration of 2, 4, 6 ng/ml. At least 5min of the steady-state period is maintained before tetanic stimulus.
Receives: Device: Tetanic stimulation; Procedure: Skin incision

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To verify the effectiveness of ANI predictability for actual surgical noxious stimuli while satisfying the individual analgesic status by pre-tetanus-induced ANI determination.

    Tetanic stimulations are applied at different effect site concentrations of remifentanil under sevoflurane anesthesia. ANI is range from 0-100. Bigger number means better analgesic level. ANI≥50 is considered to be under adequate analgesia. Tetanic stimulation is a standard tester of nociceptive stimulus. The number of ANI will fall down if the patient is feeling pain.

    Measured: Change from Baseline ANI that 2 minutes after applied tetanic stilumation

Secondary outcomes (3)
  1. The ANI predictability for tetanic noxious stimuli

    ANI is range from 0-100. Bigger number means better analgesic level. ANI≥50 is considered to be under adequate analgesia. The number of ANI will fall down if the patient is feeling pain.

    Measured: Change from Baseline Systolic Blood Pressure that 2 minutes after applied tetanic stilumation

  2. The heart rate predictability for tetanic noxious stimuli

    Heart Rate will go up if patient is feeling pain.

    Measured: Change from Baseline Heart Rate that 2 minutes after applied tetanic stilumation

  3. The Bispectral Index predictability for tetanic noxious stimuli

    Bispectral Index will go up if patient is feeling pain.

    Measured: Change from Baseline Bispectral Index that 2 minutes after applied tetanic stilumation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Oct 2021
  2. Study start25 Sep 2021
  3. Primary completion28 Feb 2023
  4. Study completion1 Mar 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05063461
Sponsor's protocol ID
00375930
Status last verified
Mar 2023
First submitted
15 Sep 2021
Last updated
22 Mar 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Yang L, Wang X, Wen H. Evaluation of the effectiveness of analgesia nociception index (ANI) predictability for surgical stimuli under personal analgesic sufficiency status (PASS) measured by pre-tetanus-induced ANI: a pilot study. J Clin Monit Comput. 2023 Dec;37(6):1585-1591. doi: 10.1007/s10877-023-01044-y. Epub 2023 Jul 7.

    PubMed 37418059

Questions about this trial

What is this clinical trial studying?

A study testing Tetanic stimulation and Skin incision in people with General Anesthesia, run by Beijing Chao Yang Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To verify the effectiveness of ANI predictability for actual surgical noxious stimuli while satisfying the individual analgesic status by pre-tetanus-induced ANI determination. (time frame: Change from Baseline ANI that 2 minutes after applied tetanic stilumation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05063461, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in